Year To Quarter End Consolidated Statement Of Comprehensive Income

Modalis Therapeutics Corporation - Filing #7581546

Concept 2022-01-01 to
2022-06-30
2021-01-01 to
2021-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-775,695,000 JPY
17,702,000 JPY
Other comprehensive income
Foreign currency translation adjustment
28,819,000 JPY
4,618,000 JPY
Other comprehensive income
28,819,000 JPY
4,618,000 JPY
Comprehensive income
-746,875,000 JPY
22,321,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-746,875,000 JPY
22,321,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.